Table 1 Comparison of patient characteristics between the non-triple-negative breast cancer (TNBC) and TNBC groups.

From: PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy

Characteristics

Total (n = 469)

non-TNBC (n = 238)

TNBC (n = 231)

p-value

Age (yr) (Mean ± SD)

47.35 ± 9.12

47.24 ± 8.98

47.46 ± 9.28

0.999

Breast operation

   

0.001

Breast-conserving surgery

292(62.4)

131(55.0)

161(70.0)

 

Total mastectomy

176(37.6)

107(45.0)

69(30.0)

 

Unknown

1

0

1

 

Axillary operation

   

0.322

No

2(0.4)

2(0.8)

0(0.0)

 

Sentinel node biopsy

67(14.3)

36(15.1)

31(13.4)

 

Axillary lymph node dissection

400(85.3)

200(84.0)

200(86.6)

 

pT stage

   

0.015

T0/is

4(0.9)

0(0.0)

4(1.7)

 

T1

178(38.0)

105(44.1)

73(31.6)

 

T2

254(54.2)

115(48.3)

139(60.2)

 

T3

30(6.4)

16(6.7)

14(6.1)

 

T4

3(0.6)

2(0.8)

1(0.4)

 

pN stage

   

0.412

N0

7(1.5)

4(1.7)

3(1.3)

 

N1

326(69.5)

167(70.2)

159(68.8)

 

N2

388(17.5)

45(18.9)

37(16.0)

 

N3

360(11.5)

22(9.2)

32(13.9)

 

Pathologic stage

   

0.992

I

17(3.6)

8(3.4)

9(3.9)

 

II

298(63.5)

152(63.9)

146(63.2)

 

III

152(32.4)

77(32.4)

75(32.5)

 

IV

2(0.4)

1(0.4)

1(0.4)

 

ER

  

-

-

Negative

54(22.7)

54(22.7)

-

-

Positive

184(77.3)

184(77.3)

-

-

PGR

  

-

-

Negative

93(39.1)

93(39.1)

-

-

Positive

145(60.9)

145(60.9)

-

-

HER2 status

  

-

-

Negative

148(66.7)

148(66.7)

-

-

Positive

74(33.3)

74(33.3)

-

-

Unknown

16

16

-

-

Histologic grade

   

 < 0.001

G1/2

195(41.8)

154(64.7)

41(18.0)

 

G3

271(58.2)

84(35.3)

187(82.0)

 

Unknown

3

0

3

 

Nuclear grade

   

 < 0.001

G1/2

191(41.0)

151(63.4)

40(17.5)

 

G3

275(59.0)

87(36.6)

188(82.5)

 

Unknown

3

0

3

 

Lymphovascular invasion

   

0.539

Absent

276(60.3)

139(58.9)

137(61.7)

 

Present

182(39.7)

97(41.1)

85(38.3)

 

Unknown

11

2

9

 

P53

   

 < 0.001

Negative

275(59.1)

168(71.5)

107(46.5)

 

Weak

31(6.7)

21(8.9)

10(4.3)

 

Intermediate

25(5.4)

11(4.7)

14(6.1)

 

Strong

134(28.8)

35(14.9)

99(43.0)

 

Unknown

4

3

1

 

Ki-67

   

 < 0.001

Low (≤ 20%)

72(35.5)

54(56.8)

18(16.7)

 

High(> 20%)

131(64.5)

41(43.2)

90(83.3)

 

Unknown

266

143

123

 

Radiotherapy

   

0.010

No

98(20.9)

61(25.6)

37(16.0)

 

Yes

371(79.1)

177(74.4)

194(84.0)

 
  1. Data shown are number (%), when not otherwise specified. SD, standard deviation; HER2, human epidermal growth factor receptor 2; ER, estrogen receptor; PGR, progesterone receptor; G, grade.